You just read:

FDA Approves Pradaxa® (dabigatran etexilate mesylate) for Prophylaxis of Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE) after Hip Replacement Surgery

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Nov 23, 2015, 10:24 ET